# Post-Approval Study of PROMUS Element™ in China

> **NCT01677585** · — · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 2016 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01677585
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2015-12
- **Final completion:** 2019-12
- **Target enrollment:** 2016 (ACTUAL)
- **Last updated:** 2022-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01677585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01677585, "Post-Approval Study of PROMUS Element™ in China". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01677585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*